Substantia nigra activity level predicts trial-to-trial adjustments in cognitive control

Carsten Nicolas Boehler1, Nico Bunzeck, Ruth M Krebs

  • 1Leibniz Institute for Neurobiology, Magdeburg, Germany. nico.boehler@duke.edu

Abstract